Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $26,130 - $33,940
1,000 New
1,000 $28,000
Q4 2021

Feb 04, 2022

SELL
$41.32 - $61.25 $413 - $612
-10 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $169,952 - $218,318
-4,330 Reduced 99.77%
10 $0
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $137,795 - $161,665
4,340 New
4,340 $159,000
Q2 2020

Aug 05, 2020

SELL
$30.12 - $36.54 $130,419 - $158,218
-4,330 Closed
0 $0
Q1 2020

May 05, 2020

SELL
$27.03 - $38.62 $32,436 - $46,344
-1,200 Reduced 21.7%
4,330 $141,000
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $17,619 - $20,087
-458 Reduced 7.65%
5,530 $241,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $185,628 - $204,490
5,988
5,988 $214,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Salzhauer Michael Portfolio

Follow Salzhauer Michael and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salzhauer Michael, based on Form 13F filings with the SEC.

News

Stay updated on Salzhauer Michael with notifications on news.